期刊
CURRENT RHEUMATOLOGY REPORTS
卷 16, 期 5, 页码 -出版社
SPRINGER
DOI: 10.1007/s11926-014-0415-x
关键词
Antiphospholipid antibodies; Antiphospholipid syndrome; Thrombosis; Venous thrombosis; Antiprothrombin; Anti-phosphatidylserine; Stroke
类别
资金
- Louise Gergel Fellowship
Antiprothrombin antibodies have been proposed as potential new biomarkers for thrombosis and/or pregnancy morbidity in the setting of the antiphospholipid syndrome (APS). Antiprothrombin antibodies are commonly detected by ELISA, using prothrombin coated onto irradiated plates (aPT), or prothrombin in complex with phosphatidylserine (aPS/PT), as antigen. Although these antibodies can co-exist in the same patient, aPT and aPS/PT seem to belong to different populations of autoantibodies. Early research explored the role of antibodies to prothrombin as potential antigenic targets for the lupus anticoagulant (LA). To date their clinical significance is being investigated and their potential role in identifying patients at higher risk of developing thrombotic events or pregnancy morbidity is being probed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据